17524 Federal Register / Vol. 74, No. 71 / Wednesday, April 15, 2009 / Notices 

1According to the letter, the State ‘‘ha[d] received 

information that [Respondent’s] last day of 

practicing at that location was the[e] date of [his] 

overdose on March 25, 2008,’’ and ‘‘had received 

written documentation that [Respondent’s] 

privileges were terminated at that location on 

March 26, 2008.’’ Gov. Motion at Attachment 1. 

doing so, this Agency does not expect 

its registrants to possess divine powers. 

It does, however, expect that its 

registrants exercise common sense and 

act responsibly. 

Respondent’s and Mr. Gregg’s 

violation in selling this product cannot 

be condoned. I therefore conclude that 

Respondent’s registration should be 

suspended for a period of six months. 

However, in light of the total record in 

this case, which establishes that 

Respondent has otherwise attempted to 

obey applicable laws and regulations, I 

conclude that the suspension should be 

stayed for a period of three years at 

which time the suspension will be 

rescinded provided Respondent does 

not commit any further violation of 

federal or state laws or regulations 

related to listed chemicals or controlled 

substances. 

Order 

Pursuant to the authority vested in me 

by 21 U.S.C. 823(h) & 824(a), as well as 

28 CFR 0.100(b) & 0.104, I order that the 

application of Gregg & Son Distributors 

to renew its DEA Certificate of 

Registration be, and it hereby is, 

granted. I further order that the DEA 

Certificate of Registration issued to 

Gregg & Son Distributors be, and it 

hereby is suspended for a period of six 

months, but that the suspension shall be 

stayed for a period of three years from 

the date of this Order provided 

Respondent complies with all 

applicable laws and regulations as set 

forth above. This Order is effective 

immediately. 

Dated: April 3, 2009. 

Michele M. Leonhart, 

Deputy Administrator. 

[FR Doc. E9–8621 Filed 4–14–09; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Federal Bureau of Investigation 

Meeting of the CJIS Advisory Policy 

Board 

AGENCY: Federal Bureau of Investigation 

(FBI), Department of Justice. 

ACTION: Meeting Notice. 

SUMMARY: The purpose of this notice is 

to announce the meeting of the Criminal 

Justice Information Services (CJIS) 

Advisory Policy Board (APB). The CJIS 

APB is a Federal advisory committee 

established pursuant to the Federal 

Advisory Committee Act (FACA). This 

meeting announcement is being 

published as required by section 10 of 

the FACA. 

The CJIS APB is responsible for 

reviewing policy issues and appropriate 

technical and operational issues related 

to the programs administered by the 

FBI’s CJIS Division, and thereafter, 

making appropriate recommendations to 

the FBI Director. The programs 

administered by the CJIS Division are 

the Integrated Automated Fingerprint 

Identification System, the Interstate 

Identification Index, Law Enforcement 

Online, National Crime Information 

Center, the National Instant Criminal 

Background Check System, the National 

Incident-Based Reporting System, Law 

Enforcement National Data Exchange, 

and Uniform Crime Reporting. 

The meeting will be open to the 

public on a first-come, first-seated basis. 

Any member of the public wishing to 

file a written statement concerning the 

CJIS Division programs or wishing to 

address this session should notify 

Senior CJIS Advisor Roy G. Weise at 

(304) 625–2730 at least 24 hours prior 

to the start of the session. The 

notification should contain the 

requestor’s name, corporate designation, 

and consumer affiliation or government 

designation along with a short statement 

describing the topic to be addressed and 

the time needed for the presentation. A 

requestor will ordinarily be allowed no 

more than 15 minutes to present a topic. 

DATES AND TIMES: The APB will meet in 

open session from 8:30 a.m. until 5 

p.m., on June 4–5, 2009. 

ADDRESSES: The meeting will take place 

at the Gaylord National, 201 Waterfront 

Street, National Harbor, Maryland, (301) 

965–2300. 

FOR FURTHER INFORMATION CONTACT: 

Inquiries may be addressed to Ms. Lori 

A. Kemp, Management and Program 

Analyst, Advisory Groups Management 

Unit, Liaison, Advisory, Training and 

Statistics Section, FBI CJIS Division; 

Module C3, 1000 Custer Hollow Road, 

Clarksburg, West Virginia 26306–0149; 

telephone (304) 625–2619; facsimile 

(304) 625–5090. 

Dated: April 1, 2009. 

Roy G. Weise, 

Senior CJIS Advisor, Criminal Justice 

Information Services Division, Federal Bureau 

of Investigation. 

[FR Doc. E9–8490 Filed 4–14–09; 8:45 am] 

BILLING CODE 4410–02–M 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. 08–58] 

John B. Freitas, D.O.; Revocation of 

Registration 

On August 29, 2008, the Deputy 

Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration, issued an Order to 

Show Cause to John B. Freitas, D.O. 

(Respondent), of Carthage, Missouri. 

The Show Cause Order proposed the 

revocation of Respondent’s DEA 

Certificate of Registration, BF2847715, 

which authorizes him to dispense 

controlled substances in schedules II 

through V as a practitioner, as well as 

the denial of any pending application to 

renew or modify the registration, on the 

ground that Respondent lacks authority 

to dispense controlled substances in 

Missouri, the State in which he is 

registered with DEA. Show Cause Order 

at 1. 

Respondent timely requested a 

hearing on the allegation; the matter was 

placed on the docket of the Agency’s 

Administrative Law Judges (ALJ). 

Thereafter, the Government moved for 

summary disposition. Motion for 

Summary Disp. at 1. The basis of the 

motion was that Respondent’s Missouri 

Controlled Substances Registration 

automatically terminated when 

Respondent ceased practicing at the 

location where he held his State 

registration and ‘‘did not notify the 

[State] of [his] change of address or a 

new Missouri practice location.’’ Id. at 

Attachment 1 (Letter of Michael R. 

Boeger, Asst. Administrator, Missouri 

Bureau of Narcotics & Dangerous Drugs, 

to Dr. John Freitas (May 13, 2008)).1

Thereafter, Respondent filed his 

response to the Government’s motion. 

Therein, Respondent acknowledged the 

State BNDD’s letter and further stated 

that he ‘‘does not deny that he no longer 

has the authority to handle controlled 

substances in the State of Missouri.’’ 

Respondent’s Response to Gov.’s Mot. 

for Summ. Disp. at 1. Respondent 

argued, however, that his state 

registration had not been ‘‘suspended, 

revoked, or denied under Missouri law 

by the BNDD,’’ and that under 21 U.S.C. 

824(a)(3), DEA’s authority to revoke is 

limited to those situations in which a 

registrant’s State authority has been 


rwilkins on PROD1PC63 with PROPOSALS